Related Experiment Video
Updated: Aug 28, 2025

Methylated DNA Immunoprecipitation
Published on: January 2, 2009
Impact of local anesthetics on epigenetics in cancer
Lucillia Bezu1,2,3, Oliver Kepp1,2, Guido Kroemer1,2,4
1Equipe Labellisée Par La Ligue Contre Le Cancer, Université de Paris, Sorbonne Université, INSERM UMR1138, Centre de Recherche des Cordeliers, Institut Universitaire de France, Paris, France.
Abstract:
Defective silencing of tumor suppressor genes through epigenetic alterations contributes to oncogenesis by perturbing cell cycle regulation, DNA repair or cell death mechanisms. Reversal of such epigenetic changes including DNA hypermethylation provides a promising anticancer strategy. Until now, the nucleoside derivatives 5-azacytidine and decitabine are the sole DNA methyltransferase (DNMT) inhibitors approved by the FDA for the treatment of specific hematological cancers. Nevertheless, due to their nucleoside structure, these inhibitors directly incorporate into DNA, which leads to severe side effects and compromises genomic stability. Much emphasis has been placed on the development of less toxic epigenetic modifiers. Recently, several preclinical studies demonstrated the potent epigenetic effects of local anesthetics, which are routinely used during primary tumor resection to relief surgical pain. These non-nucleoside molecules inhibit DNMT activity, affect the expression of micro-RNAs and repress histone acetylation, thus exerting cytotoxic effects on malignant cells. The in-depth mechanistic comprehension of these epigenetic effects might promote the use of local anesthetics as anticancer drugs.
Insights
Local anesthetics show potential as novel anticancer agents by reversing epigenetic alterations like DNA hypermethylation. These non-nucleoside drugs offer a less toxic alternative to current treatments, targeting cancer cells through epigenetic modifications.
Area of Science:
- Oncology
- Epigenetics
- Pharmacology
Background:
- Epigenetic alterations, including DNA hypermethylation, silence tumor suppressor genes, promoting cancer development.
- Current DNA methyltransferase (DNMT) inhibitors (5-azacytidine, decitabine) are nucleoside derivatives with significant side effects and genotoxicity.
- There is a need for less toxic epigenetic modifiers for cancer therapy.
Purpose of the Study:
- To explore the anticancer potential of local anesthetics as epigenetic modifiers.
- To investigate the mechanisms by which local anesthetics exert cytotoxic effects on cancer cells.
Main Methods:
- Review of preclinical studies on local anesthetics' epigenetic effects.
- Analysis of DNMT inhibition, micro-RNA expression, and histone acetylation modulation by local anesthetics.
Main Results:
- Local anesthetics act as non-nucleoside DNMT inhibitors.
- These agents modulate micro-RNA expression and repress histone acetylation.
- Local anesthetics demonstrate cytotoxic effects on malignant cells through epigenetic mechanisms.
Conclusions:
- Local anesthetics possess potent epigenetic activities relevant to cancer therapy.
- Understanding these mechanisms could establish local anesthetics as viable anticancer drugs.
- Non-nucleoside epigenetic modifiers like local anesthetics offer a promising, less toxic therapeutic avenue.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Local Anesthetics: Adverse Effects
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Local Anesthetics: Pharmacokinetics
Local Anesthetics: Chemistry and Structure-Activity Relationship
Local Anesthetics: Mechanism of Action
Local anesthetics are amphiphilic molecules consisting of a hydrophobic aromatic part linked to a hydrophilic group by an ester or amide linkage. They are weak bases and are usually available as salts, which increases their solubility and stability. Once administered, LAs exist in the body either...
Local Anesthetics: Clinical Application as Epidural Anesthesia
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...

